Legal Opinion

In re Viagra (Sildenafil Citrate) Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided April 7, 2016No. MDL No. 2691PublishedCited by 1 opinion

1Opinion of the Court

TRANSFER ORDER

Sarah S. Vance, Chair

Before the Panel:* Plaintiffs in seven actions move under 28 U.S.C. § 1407 to centralize this litigation in the Northern District of California.1 The litigation consists of fourteen actions pending in six districts, as listed on Schedule A. Since the filing of the motion, the Panel has been notified of fifteen related actions in seven additional districts.2 All responding plaintiffs and defendant Pfizer, Inc., support or do not oppose centralization in the Northern District of California.

On the basis of the papers filed and the hearing session held, we find…

2Cited by1 opinion

  1. In re Viagra (Sildenafil Citrate) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API